BamSEC and AlphaSense Join Forces
Learn More

Pulmonx Corporation – Material Contracts

NASDAQ: LUNG    
Share price (3/25/26): $1.30    
Market cap (3/25/26): $54.9 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.42
from 10-K 6 pages Pulmonx Corporation Rsu Award Grant Notice
12/34/56
EX-10.41
from 10-K 7 pages Pulmonx Corporation Stock Option Grant Notice
12/34/56
EX-10.3
from 8-K 16 pages Pulmonx Corporation Warrant to Purchase Common Stock
12/34/56
EX-10.2
from 8-K 36 pages Security Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Pulmonx Corporation Amended and Restated Non-Employee Director Compensation Policy Approved by the Compensation Committee of the Board of Directors August 26, 2025
12/34/56
EX-10.6
from 8-K 7 pages Dear Derrick: On Behalf of Pulmonx (The “Company” or “Pulmonx”) I Am Pleased to Offer You Employment With the Company Beginning on November 3, 2025 or a Date That Is Mutually Agreed Upon (The “Start Date”) on the Terms Described Below. Position You Will Start in a Full-Time, Exempt Position as Chief Operating Officer and Chief Financial Officer, Working Out of the Company’s Office in Redwood City. You Will Report to the Company’s CEO. Compensation
12/34/56
EX-10.5
from 8-K 6 pages Pulmonx Corporation Consulting Agreement Effective Date: October 28, 2025
12/34/56
EX-10.4
from 8-K 7 pages October 24, 2025 1.separation. Your Last Day of Work With the Company and Your Employment Termination Date Will Be October 27, 2025 (The “Separation Date”). 2.accrued Salary and Paid Time Off. on the Separation Date, the Company Will Pay You All Accrued Salary and All Accrued and Unused Vacation Earned Through the Separation Date, Subject to Standard Payroll Deductions and Withholdings. You Are Entitled to This Payment by Law
12/34/56
EX-10.3
from 8-K 7 pages Dear Glen: On Behalf of Pulmonx (The “Company” or “Pulmonx”) I Am Pleased to Offer You Employment With the Company Beginning on October 27, 2025 or a Date That Is Mutually Agreed Upon (The “Start Date”) on the Terms Described Below. Position You Will Start in a Full-Time, Exempt Position as President and Chief Executive Officer, Working Out of the Company’s Office in Redwood City. You Will Report to the Pulmonx Board of Directors (The “Board”). You Will Also Be Appointed to the Board. Compensation
12/34/56
EX-10.2
from 8-K 6 pages Pulmonx Corporation Consulting Agreement Effective Date: October 28, 2025
12/34/56
EX-10.1
from 8-K 7 pages October 24, 2025 1.separation. Your Last Day of Work With the Company and Your Employment Termination Date Will Be October 27, 2025 (The “Separation Date”). 2.accrued Salary and Paid Time Off. on the Separation Date, the Company Will Pay You All Accrued Salary and All Accrued and Unused Vacation Earned Through the Separation Date, Subject to Standard Payroll Deductions and Withholdings. You Are Entitled to This Payment by Law
12/34/56
EX-10.34
from 10-K 2 pages Material contract
12/34/56
EX-10.2
from 8-K 9 pages Third Amendment to Consent to Sublease Agreement
12/34/56
EX-10.1
from 8-K 26 pages Third Amendment to Office Lease
12/34/56
EX-10.1
from 8-K 5 pages March 19, 2024 Position You Will Start in a Full-Time, Exempt Position as Chief Financial Officer Working Out of the Company’s Office in Redwood City, California. You Will Report to Me, Steve Williamson, President and Chief Executive Officer (CEO). Compensation
12/34/56
EX-10.30
from 10-K 3 pages Pulmonx Corporation Amended and Restated Non-Employee Director Compensation Policy Approved by the Compensation Committee of the Board of Directors December 13, 2023
12/34/56
EX-10.2
from 8-K 5 pages Dear Steve: On Behalf of Pulmonx (The “Company” or “Pulmonx”) I Am Pleased to Offer You Employment With the Company Beginning on March 15, 2024 or a Date That Is Mutually Agreed Upon (The “Start Date”) on the Terms Described Below. Position You Will Start in a Full-Time, Exempt Position as President and Chief Executive Officer. You Will Report to the Pulmonx Board of Directors (The “Board”). You Will Also Be Appointed to the Board. Compensation
12/34/56
EX-10.1
from 8-K 1 page February 20, 2024 via Email/Docusign Glendon E. French President and Chief Executive Officer Dear Glen
12/34/56
EX-10.1
from 10-Q 6 pages Pulmonx Corporation Consulting Agreement Effective Date: November 1, 2023
12/34/56
EX-10.2
from 10-Q 5 pages Second Amendment to Sublease
12/34/56